Jeff Yass’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCT
Jeff Yass's NVCT Position: Q3 2026 in Review
Jeff Yass reduced its Nuvectis Pharma (NVCT) stake by 33% in Q3 2026, selling an estimated $1.52M and leaving 145,121 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #5375.
Jeff Yass first reported a position in NVCT in Q4 2023 and has held it in 9 quarters since. The position peaked at $4M in Q2 2026. 95 funds tracked by Wall St. Rank hold NVCT as of Q3 2026.
- Jeff Yass held 145,121 shares of Nuvectis Pharma worth $3.06M as of Q3 2026.
- Jeff Yass sold 72,165 Nuvectis Pharma shares in Q3 2026, an estimated $1.52M.
- Nuvectis Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #5375 holding.
- Jeff Yass first reported a position in Nuvectis Pharma in Q4 2023 and has held it in 9 quarters since.
- Jeff Yass's Nuvectis Pharma position peaked at $4M in Q2 2026.
- 95 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.